Loading...
 
Toggle Health Problems and D

Vaccinations resulted in increased office visits for children 16 months later - Nov 2020

Office Visits vs days since birth

Note: Increased Office Visits for vaccinated children start about day 500
Image

VitaminDWiki

11 years of office visits and vaccination data from a pediatric practice in Portland, Oregon
This analysis can easily be performed on 1,000's of other datasets around the world
   yet this study appears to be the first to have done so

Note: Doctors are told to report health problems that occur soon after a vaccination
   they rarely notice/report health problems which occur 500+ days later


See also web

48 minute video of the first author
Congress asked the CDC to do this kind of study back in 1986
Found similar results when limiting the data by age of the patient, etc. (in PDF supplement)
50X higher risk of ADHD if vaccinated
Aluminum in the vaccine is due to vaccines being shipped in Aluminum containers
They are trying to get funding ($60k) for phase II of the study in progress - look at vaccines:

  • Aluminum
  • Live vs dead virus

He wrote a book on possible causes of Autism
He is very concerned that NIH, CDC, and FDA get money from vaccine manufacturers
His website The Institute for Pure and Applied Knowledge 2020 publications follow

  • Lyons-Weiler J. 2020. Pathogenic Priming Likely Contributes to Serious and Critical Illness and Mortality in COVID-19 via Autoimmunity. J Transl Autoimmun. 2020 Apr 9:100051. doi: 10.1016/j.jtauto.2020.100051.
  • Lyons-Weiler, J, G McFarland, E La Joie. 2020. Impact of catch-up vaccination on aluminum exposure due to new laws and post social distancing. J Trace Elements in Medicine and Biology, Volume 62, December 2020, 126649
  • McFarland, G, E La Joie, P Thomas and J Lyons-Weiler. 2020. Acute Exposure and Chronic Retention of Aluminum in Three Vaccine Schedules and Effects of Genetic and Environmental Variation. J Trace Elements in Medicine and Biology 58:126444. https://www.sciencedirect.com/science/article/pii/S0946672X19305784
  • Lyons-Weiler, J. 2020. Pediatric Dosing of Aluminum in Vaccines: Comparisons of Schedules. Presented at UCLA, 1/5/2020 [Slides (pdf)] [Slides (.ppt)

See also VitaminDWiki


Vaccines may increase the risk of Autism

Image


Observation: Many of the health problems are prevented and treated by Vitamin D
Speculation: Vaccine ==> reduced Vitamin D==> health problem


COVID-19 treated by Vitamin D - studies, reports, videos
As of Sept 21, 2021, the page had:  34 trials6 trial results,   23 meta-analyses and reviews,   63 observations,   35 recommendations,   55 associations,  89 speculations,  48 videos   see related:   Governments,   HealthProblems,   Hospitals,  Dark Skins,   26 risk factors are ALL associated with low Vit D,   Recent Virus pages   Fight COVID-19 with 50K Vit D weekly   Vaccines


Comment on this study by a Pediatric Nurse (LLB)
Most office visits in young children are well checks/immunization visits. Therefore, these study results are meaningless because the metric is meaningless.

If you studied prescriptions for kids you'd have a little better numbers, but even then, the same people who are attentive to their children's health and trust the medical system will be bringing their kids in for antibiotics for ear infections, instead of letting the kids attempt to ride it out.

Hospitalizations would be a great better metric.

In addition, most pediatricians are pretty persuasive about immunizations, particularly in kids with underlying health problems. So kids with serious asthma, etc. are more likely to be vaccinated.


Paper was retracted by the publisher July 2021 (when there is great COVID-19 vaccine hesitancy)

Authors did not agree with the retraction reason PDF

One of the charts: More likely to have office visits from age 250 - 600 days for Anemia if vaccinated
Image

Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses Along the Axis of Vaccination

Int. J. Environ. Res. Public Health 2020, 17(22), 8674; https://doi.org/10.3390/ijerph17228674
James Lyons-Weiler 1, jim at ipaknowledge.org OrcID and Paul Thomas 2
1 The Institute for Pure and Applied Knowledge, Pittsburgh, PA 15101, USA
2 Integrative Pediatrics, Portland, OR 97225

  • Paul is the author of the book “The Vaccine-Friendly Plan: Dr. Paul’s Safe and Effective Approach to Immunity and Health—from Pregnancy Through Your Child’s Teen Years” by Balantine Books 2016

 Download the PDF from VitaminDWiki
Office visits for fever increased with % vaccine acceptance
Image

Increased billable office visits: with and without vaccine (all statistically significant)
Image

We performed a retrospective analysis spanning ten years of pediatric practice focused on patients with variable vaccination born into a practice, presenting a unique opportunity to study the effects of variable vaccination on outcomes. The average total incidence of billed office visits per outcome related to the outcomes were compared across groups (Relative Incidence of Office Visit (RIOV)). RIOV is shown to be more powerful than odds ratio of diagnoses. Full cohort, cumulative incidence analyses, matched for days of care, and matched for family history analyses were conducted across quantiles of vaccine uptake. Increased office visits related to many diagnoses were robust to days-of-care-matched analyses, family history, gender block, age block, and false discovery risk.
Many outcomes had high RIOV odds ratios after matching for days-of-care (e.g.,

  • anemia (6.334),
  • asthma (3.496),
  • allergic rhinitis (6.479), and
  • sinusitis (3.529), all significant under the Z-test).

Developmental disorders were determined to be difficult to study due to extremely low prevalence in the practice, potentially attributable to high rates of vaccine cessation upon adverse events and family history of autoimmunity.
Remarkably, zero of the 561 unvaccinated patients in the study had attention deficit hyperactivity disorder (ADHD) compared to 0.063% of the (partially and fully) vaccinated.
The implications of these results for the net public health effects of whole-population vaccination and with respect for informed consent on human health are compelling. Our results give agency to calls for research conducted by individuals who are independent of any funding sources related to the vaccine industry.

While the low rates of developmental disorders prevented sufficiently powered hypothesis testing, it is notable that the overall rate of autism spectrum disorder (0.84%) in the cohort is half that of the US national rate (1.69%). The practice-wide rate of ADHD was roughly half of the national rate.

The data indicate that unvaccinated children in the practice are not unhealthier than the vaccinated and indeed the overall results may indicate that the unvaccinated pediatric patients in this practice are healthier overall than the vaccinated.

Clipped from PDF

  • "We have been keenly aware of the brewing political controversies around vaccination studies, including the public’s increased awareness of the dearth of long-term randomized prospective clinical studies that use inert placebos such as saline."
  • "Parents are almost universally told by their child’s health care provider that the health issue was not due to the vaccine, in spite of growing evidence in the scientific literature that supports both plausible mechanisms of action for chronic illnesses including epidemiological associations. "

This study was cited by 6 publications at of Sept 2021

  • Vaccine Practice Payment Schedules Create Perverse Incentives for Unnecessary Medical Procedures – at What Cost to Patients?
  • Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data
  • Health effects in vaccinated versus unvaccinated children with covariates for breastfeeding status and type of birth


References

  1. Benn, C.S.; Fisker, A.B.; Rieckmann, A.; S0rup, S.; Aaby, P.Vaccinology: Time to change the paradigm? Lancet Infect Dis. 2020, 20, e274-e283. [[CrossRef]
  2. Aaby, P.; Jensen, H.; Samb, B.; Cisse, B.; Sodemann, M.; Jakobsen, M.; Poulsen, A.; Rodrigues, A.; Lisse, I.M.; Simondon, F.; et al. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: Reanalysis of West African studies. Lancet 2003, 361, 2183-2188. [CrossRef]
  3. CDC. Report an Adverse Event to VAERS. 2020. Available online: https://vaers.hhs.gov/reportevent.html (accessed on 15 August 2020).
  4. Tan, T.Q.; Gerbie, M.V.; Flaherty, J.P. The Vaccine Handbook. Oxford University Press: New York, NY, USA, 2017.
  5. Lazarus, R.; Klompas, M. Electronic Support for Public Health-Vaccine Adverse Event Reporting System (ESP:VAERS). Grant. Final Report, GrantID: R18 HS 017045. 2010. Available online: https://healthit.ahrq.gov/sites/default/files/docs/publication/r18hs017045-lazarus-final-report-2011.pdf (accessed on 16 August 2020).
  6. Institutes of Medicine (National Academy of Sciences) Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule; Board on Population Health and Public Health Practice; Institute of Medicine. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. National Academies Press (US): Washington, DC, USA, 27 March 2013.
  7. CDC. White Paper on Studying the Safety of the Immunity Schedule: For the Vaccine Safety Datalink 2018. Available online: https://www.cdc.gov/vaccinesafety/pdf/whitepapersafety_web.pdf (accessed on 14 August 2020).
  8. Glanz, J.M.; Newcomer, S.R.; Jackson, M.L.; Omer, S.B.; Bednarczyk, R.A.; Shoup, J.A.; DeStefano, F.; Daley, M.F. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink. Vaccine 2016, 34, A1-A29. [CrossRef]
  9. Mawson, A.R.; Ray, B.D.; Bhuiyan, A.R.; Jacob, B. Pilot comparative study on the health of vaccinated and unvaccinated 6- to 12- year old U.S. children. J. Transl. Sci. 2017, 3,1-12. [CrossRef]
  10. Schmitz, R.; Poethko-Muller, C.; Reiter, S.; Schlaud, M. Vaccination status and health in children and adolescents: Findings of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Dtsch. Arztebl. Int. 2011,108, 99-104. [CrossRef]
  11. Mogensen, S.W.; Andersen, A.; Rodrigues, A.; Benn, C.S.; Aaby, P. The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine Among Young Infants in an Urban African Community: A Natural Experiment. EBioMedicine 2017,17,192-198. [CrossRef] [PubMed]
  12. McDonald, K.L.; Huq, S.I.; Lix, L.M.; Becker, A.B.; Kozyrskyj, A.L. Delay in diphtheria, pertussis, tetanus vaccination is associated with a reduced risk of childhood asthma. J. Allergy Clin. Immunol. 2008,121, 626-631. [CrossRef] [PubMed]
  13. Gallagher, C.; Goodman, M. Hepatitis B triple series vaccine and developmental disability in US children aged 1-9 years. Tox. Environ. Chem. 2008, 5, 997-1008. [CrossRef]
  14. Hooker, B.S.; Miller, N.Z. Analysis of health outcomes in vaccinated and unvaccinated children: Developmental delays, asthma, ear infections and gastrointestinal disorders. SAGE Open Med. 2020, 8, 1-11. [CrossRef] [PubMed]
  15. McFarland, G.; LaJoie, E.; Lyons-Weiler, J. Acute exposure and chronic retention of aluminum in three vaccine schedules and effects of genetic and environmental variation. J. Trace. Elem. Med. Biol. 2020, 58,126444. [CrossRef]
  16. Vaccine Safety Commission. 2020. Available online: https://vaccinesafetycommission.org (accessed on 24 August 2020).
  17. Hurwitz, E.L.; Morgenstern, H. Effects of diptheria-tetanus-pertussis or tetanus vaccine on allergies and allergy-related respiratory symptoms among children and adolescents in the United States. J. Manip. Physiol. Therap. 2000, 23, 81-90. [CrossRef]
  18. Glanz, J.M.; Wagner, N.M.; Narwaney, K.J.; Shoup, J.A.; McClure, D.L.; McCormick, E.V.; Daley, M.F. A mixed methods study of parental vaccine decision making and parent-provider trust. Acad. Pediatr. 2013, 13, 481-488. [CrossRef] [PubMed]
  19. Vansteelandt, S.; Bekaert, M.; Claeskens, G. On Model Selection and Model Misspecification in Causal Inference. SSRN Electron. J. 2010,21, 7-30. [CrossRef]
  20. Schisterman, E.F.; Cole, S.R.; Platt, R.W. Overadjustment Bias and Unnecessary Adjustment in Epidemiologic Studies. Epidemiology 2009, 20, 488-495. [CrossRef]
  21. George, B.J.; Beasley, T.M.; Brown, A.W.; Dawson, J.; Dimova, R.; Divers, J.; Goldsby, T.U.; Heo, M.; Kaiser, K.A.; Keith, S.W.; et al. Common scientific and statistical errors in obesity research. Obesity 2016, 24, 781-790. [CrossRef]
  22. CDC. Reporting Adverse Events. Available online: https://www.cdc.gov/vaccinesafety/hcproviders/ reportingadverseevents.html (accessed on 24 August 2020).
  23. US Department of Health and Human Services. Vaccine Adverse Event Reporting System: Report an Adverse Event to VAERS. 2020. Available online: https://vaers.hhs.gov/reportevent.html (accessed on 1 March 2020).
  24. Cowling, B.J.; Fang, V.J.; Nishiura, H.; Chan, K.-H.; Ng, S.; Ip, D.K.M.; Chiu, S.S.; Leung, G.M.; Peiris, J.S.M. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin. Infect. Dis. 2012, 54,1778-1783. [CrossRef]
  25. Wolff, G.G. Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season. Vaccine 2020, 38, 350-354. [CrossRef]
  26. Papageorgiou, V.; Vargiami, E.; Kontopoulos, E.; Kardaras, P.; Economou, M.; Athanassiou-Mataxa, M.; Kirkham, F.J.; Zafeiriou, D.I. Association between iron deficiency and febrile seizures. Eur. J. Paediatr. Neurol. 2015,19, 591-596. [CrossRef]
  27. Crepeaux, G.; Gherardi, R.K.; Authier, F.-J. ASIA, chronic fatigue syndrome, and selective low dose neurotoxicity of aluminum adjuvants. J. Allergy Clin. Immunol. Pract. 2018, 6, 707. [CrossRef]
  28. Exley, C. An aluminum adjuvant in a vaccine is an acute exposure to aluminum. J. Trace Elements Med. Biol. 2020,57, 57-59. [CrossRef]
  29. Crepeaux, G.; Eidi, H.; David, M.-O.; Baba-Amer, Y.; Tzavara, E.; Giros, B.; Authier, F.-J.; Exley, C.; Shaw, C.A.; Cadusseau, J.; et al. Non-linear dose-response of aluminum hydroxide adjuvant particles: Selective low dose neurotoxicity. Toxicology 2017, 375,48-57. [CrossRef] [PubMed]
  30. Gherardi, R.K.; Crepeaux, G.; Authier, F.-J. Myalgia and chronic fatigue syndrome following immunization: Macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system. Autoimmun. Rev. 2019,18,691-705. [CrossRef] [PubMed]
  31. Masson, J.-D.; Crepeaux, G.; Authier, F.-J.; Exley, C.; Gherardi, R.K. Critical analysis of reference studies on the toxicokinetics of aluminum-based adjuvants. J. Inorg. Biochem. 2018,181, 87-95. [CrossRef] [PubMed]
  32. Mold, M.; Umar, D.; King, A.; Exley, C. Aluminium in brain tissue in autism. J. Trace Elem. Med. Biol. 2018, 46, 76-82. [CrossRef] [PubMed]
  33. Morris, G.; Puri, B.K.; Frye, R.E. The putative role of environmental aluminium in the development of chronic neuropathology in adults and children. How strong is the evidence and what could be the mechanisms involved? Metab. Brain Dis. 2017, 32,1335-1355. [CrossRef] [PubMed]
  34. Petrik, M.S.; Wong, M.C.; Tabata, R.C.; Garry, R.F.; Shaw, C.A. Aluminum Adjuvant Linked to Gulf War Illness Induces Motor Neuron Death in Mice. NeuroMolecular Med. 2007, 9, 83-100. [CrossRef]
  35. Erigolet, M.; Eaouizerate, J.; Ecouette, M.; Ragunathan-Thangarajah, N.; Eaoun-Sebaiti, M.; Gherardi, R.K.; Ecadusseau, J.; Authier, F.-J. Clinical Features in Patients with Long-Lasting Macrophagic Myofasciitis. Front. Neurol. 2014, 5, 230. [CrossRef]
  36. Lyons-Weiler, J. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. J. Transl. Autoimmun. 2020, 3,1-5. [CrossRef]
Title change made April 2021 caused the visitor count to reset.
There have actually been 1583 visitors to this page since it was originally made




Created by admin. Last Modification: Monday September 20, 2021 15:16:03 GMT-0000 by admin. (Version 44)

Attached files

ID Name Comment Uploaded Size Downloads
16244 Retraction - Lyons-Weiler.pdf PDF 2021 admin 20 Sep, 2021 15:10 221.24 Kb 6
16243 Vacc vs unvacc.jpg admin 20 Sep, 2021 15:06 56.53 Kb 17
16242 VaccinatedvsUnvaccinatedChildrenHookerMillerJune2021.pdf admin 20 Sep, 2021 15:06 517.37 Kb 6
16241 Italian vaccination.pdf admin 20 Sep, 2021 14:52 552.61 Kb 4
15606 incentives T1.jpg admin 20 May, 2021 22:28 52.35 Kb 146
15605 Perverce incentives.pdf PDF 2021 admin 20 May, 2021 22:28 340.63 Kb 89
14746 Increase all health problems.jpg admin 20 Dec, 2020 02:56 82.17 Kb 333
14745 Office visit conditions.jpg admin 20 Dec, 2020 02:47 66.71 Kb 56
14744 Increased office visits fever.jpg admin 20 Dec, 2020 02:33 43.30 Kb 294
14733 Anemia vaccination.jpg admin 17 Dec, 2020 17:41 15.37 Kb 336
14731 Increased office visits if vaccinated.pdf PDF 2020 admin 17 Dec, 2020 16:25 1.71 Mb 123
14730 Vaccinatiion increased office visits.jpg admin 17 Dec, 2020 16:24 201.35 Kb 367
See any problem with this page? Report it (FINALLY WORKS)